To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis

Clinical trial NCT07061925 · COMPLETED

Trial details

NCT number: NCT07061925
Sponsor: Korea Arlico Pharm. Co., Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Bronchitis

Start date: 2025-04-23
Primary completion: 2025-11-21
Enrollment: 169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.